Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery

This study has suspended participant recruitment.
(Drug Supply Issues)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Pediatric Brain Tumor Consortium Identifier:
First received: October 14, 2013
Last updated: April 4, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)